News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Conference News EuroPCR 2017 Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis Michael O'Riordan May 26, 2017
Presentation JIM 2017 Complete Cerebral Embolic Protection Utilizing TriGuard™ Presenter: Azeem Latib February 10, 2017